Medicare billing address
CMS Medicare provider billing file
30 Monument RdSuite 1100
York, PA 17403
CMS public data · NPI 1295879633
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Jefferson H Lee, MD
Specialty
Credential
MD
NPI
1295879633
Primary source state
PA
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Jefferson H Lee, MD from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
30 Monument RdCMS Doctors & Clinicians file
1001 S George StCMS Doctors & Clinicians file
1001 S George St 2Nd FloorCMS Doctors & Clinicians file
12 St Paul DrIn the 2024 CMS provider billing file, this NPI had 2,046 Medicare beneficiaries and 4,890 total services. The average beneficiary age was 78, and the average HCC risk score was 1.9.
Total Medicare allowed amount
$276,787.18
Total Medicare payment amount
$203,989.50
Medicare beneficiaries
2,046
Total services
4,890
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
75%
CMS beneficiary-panel share
Atrial fibrillation
65%
CMS beneficiary-panel share
Ischemic heart disease
55%
CMS beneficiary-panel share
Heart failure
54%
CMS beneficiary-panel share
Chronic kidney disease
44%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 1,291 | $19.37 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 832 | $27.77 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 438 | $34.39 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 349 | $73.87 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 316 | $13.35 |
| Programming of dual lead pacemaker system | 228 | $72.82 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 192 | $120.03 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 120 | $7.61 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 75 | $10.78 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 75 | $21.53 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1295879633. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Flecainide Acetate | Flecainide Acetate | 90 | 139.3 | $1,904.71 |
| 2 | Eliquis | Apixaban | 62 | 128 | $70,835.57 |
| 3 | Dofetilide | Dofetilide | 31 | 51 | $13,119.74 |
| 4 | Amiodarone Hcl | Amiodarone Hcl | 26 | 36.5 | $372.15 |
| 5 | Metoprolol Succinate | Metoprolol Succinate | 22 | 54 | $459.62 |
| 6 | Carvedilol | Carvedilol | 19 | 23 | $41.23 |
| 7 | Xarelto | Rivaroxaban | 14 | 34 | $17,449.47 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
University Of Pittsburgh School Of Medicine
Graduation year
2004
Group/practice field
Wellspan Medical Group
Telehealth reported
Yes
Secondary specialty fields reported by CMS: Cardiovascular Disease (Cardiology), Internal Medicine.
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.